132 related articles for article (PubMed ID: 17901069)
1. Urinary excretion of endothelin-1 (ET-1), transforming growth factor- beta1 (TGF- beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial.
Grenda R; Wühl E; Litwin M; Janas R; Sladowska J; Arbeiter K; Berg U; Caldas-Afonso A; Fischbach M; Mehls O; Sallay P; Schaefer F;
Nephrol Dial Transplant; 2007 Dec; 22(12):3487-94. PubMed ID: 17901069
[TBL] [Abstract][Full Text] [Related]
2. Urinary transforming growth factor-β1 in children with obstructive uropathy.
Zieg J; Blahova K; Seeman T; Bronsky J; Dvorakova H; Pechova M; Janda J; Matousovic K
Nephrology (Carlton); 2011 Aug; 16(6):595-8. PubMed ID: 21382126
[TBL] [Abstract][Full Text] [Related]
3. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
4. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
Liu BC; Zhang L; Lv LL; Wang YL; Liu DG; Zhang XL
Am J Nephrol; 2006; 26(5):483-90. PubMed ID: 17095863
[TBL] [Abstract][Full Text] [Related]
5. Urinary fibrogenic cytokines ET-1 and TGF-β1 are associated with urinary angiotensinogen levels in obese children.
Correia-Costa L; Morato M; Sousa T; Cosme D; Guimarães JT; Guerra A; Schaefer F; Afonso AC; Azevedo A; Albino-Teixeira A
Pediatr Nephrol; 2016 Mar; 31(3):455-64. PubMed ID: 26482255
[TBL] [Abstract][Full Text] [Related]
6. Conversion from calcineurin inhibitors to sirolimus in kidney transplant patients reduces the urinary transforming growth factor-beta1 concentration.
Saurina A; Campistol JM; Lario S; Oppenheimer F; Diekmann F
Transplant Proc; 2007 Sep; 39(7):2138-41. PubMed ID: 17889117
[TBL] [Abstract][Full Text] [Related]
7. [Urinary TGF-beta1 excretion in children with renal cysts].
Biernacka A; Zoch-Zwierz WM; Wasilewska A; Porowski T; Niewiarowska A; Tenderenda E
Przegl Lek; 2006; 63 Suppl 3():94-6. PubMed ID: 16898500
[TBL] [Abstract][Full Text] [Related]
8. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
Tsau YK; Jou ST; Ni YH
Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
[TBL] [Abstract][Full Text] [Related]
9. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
[TBL] [Abstract][Full Text] [Related]
11. Genetic control of VEGF and TGF-beta1 gene polymorphisms in childhood urinary tract infection and vesicoureteral reflux.
Yim HE; Bae IS; Yoo KH; Hong YS; Lee JW
Pediatr Res; 2007 Aug; 62(2):183-7. PubMed ID: 17597658
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
13. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats.
Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E
Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155
[TBL] [Abstract][Full Text] [Related]
16. [Urinary excretion of fibrogenic and antifibrotic growth factors in type 1 diabetic patients: the interrelationship with diabetic nephropathy].
Bondar' IA; Klimontov VV; Parfent'eva EM; Romanov VV; Nadeev AP
Ter Arkh; 2012; 84(6):36-40. PubMed ID: 22997916
[TBL] [Abstract][Full Text] [Related]
17. [Influence of enteral nutrition therapy on serum angiogenic growth factors concentrations in children].
Wedrychowicz A; Kowalska-Duplaga K; Pieczarkowski S; Tomasik P; Spodaryk M; Fyderek K
Przegl Lek; 2010; 67(1):31-5. PubMed ID: 20509569
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of TGF-β1 in children with primary IgA nephropathy].
Zhu HT; Ru L; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):749-53. PubMed ID: 25008886
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
Zhu S; Liu Y; Wang L; Meng QH
Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
[TBL] [Abstract][Full Text] [Related]
20. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
